[1] 李春霞,卜星彭,李丽,等.老年慢性心力衰竭风险评估临床应用及心血管不良事件危险因素的预测分析[J].中华老年心脑血管病杂志, 2022, 24(8): 815-819.
[2] 周芸华,张颖.慢性心力衰竭中血清HCY和NT-proBNP和CysC及D-二聚体的联合诊断及预后评估价值[J].当代医学, 2020, 26(24):128-130.
[3] Bouillanne O, Morineau G, Dupont C,et al.Geriatric Nutritional Risk Index: a new index for evaluating at-risk elderly medical patients.[J].The American Journal of Clinical Nutrition: Official Journal of the American Society for Clinical Nutrition, 2005,28(4):777-783.
[4] 中华医学会,中华医学会杂志社,中华医学会全科医学分会,等.慢性心力衰竭基层诊疗指南(2019年)[J].中华全科医师杂志, 2019, 18(10):936-947.
[5] 徐娟娟,沈正军,倪斌,等. 慢性心力衰竭患者血清Lp-PLA2、s Sema4D的表达及临床意义[J]. 疑难病杂志,2020,19(1):8-11,16.
[6] 张海平,赵静敏,屠艳辉,等. 慢性心力衰竭患者血清SDC4、Cat S水平与心室重构及预后的关系[J]. 疑难病杂志,2022,21(7): 700-5,710.
[7] Ertem AG, Yayla C, Acar B,et al.Procalcitonin as a new indicator of inflammation[J].Angiology, 2017,68(1):83.
[8] Piek A,Du W,de Boer RA,et a1.Novel heart failure biomarkers:why do we fail to exploit their potential[J]. Crit Rev Clin Lab Sci,2018,55(4):246-263.
[9] Kelly D,Khan SQ,Dhillon O,et al.Procalcitonin as a prognostic marker in patients with acute myocardial infarction[J].Biomarkers,2010,15(4):325-331.
[10] Alvelos M, Lourenco P, Dias C, et al.Prognostic value of neutrophil gelatinase-associated lipocalin in acute heart failure[J]. Int J Cardiol,2013,165(7):51-55.
[10] 刘旭,王夜明. 血清和肽素、糖链抗原125及氨基末端脑钠肽前体水平与慢性心力衰竭患者心室重构及心功能的关系研究[J]. 实用心脑肺血管病杂志,2018,26(11):50-53.
[12] 石桂芳,李彦芳,孙秀全,等.血清RBP4,NT-proBNP检测联合MNA评分与慢性心力衰竭患者病情严重程度及近期预后的关系[J].分子诊断与治疗杂志, 2023, 15(4):589-593.
[13] Habaybeh D, Moraes M B D, Slee A, et al. Nutritional interventions for heart failure patients who are malnourished or at risk of malnutrition or cachexia: a systematic review and meta-analysis[J].Heart Failure Reviews, 2020,26(5):1103-1118.
[14] 林德文,陈泽伦,柳雯,等.老年人营养风险指数联合血清TIMP-2对老年慢性心力衰竭患者预后的评估价值[J].疑难病杂志, 2022, 21(3):226-231. |
